[The association between bronchiectasis, systemic inflammation, and tumor necrosis factor alpha]
Miguel Angel Martínez-García1, Miquel Perpiñá-Tordera, Pilar Román-Sánchez
1Unidad de Neumología. Hospital General de Requena, Requena, Valencia, Spain. miangel@comv.es
Archivos De Bronconeumologia
|January 29, 2008
Summary
Systemic inflammation, marked by tumor necrosis factor alpha (TNF-alpha), is linked to increased bronchiectasis severity. Higher TNF-alpha levels correlate with more severe disease, respiratory failure, and Pseudomonas aeruginosa colonization in stable patients.
Area of Science:
- Pulmonary Medicine
- Immunology
- Inflammation Research
Context:
- Bronchiectasis is a chronic respiratory condition characterized by airway dilation.
- Systemic inflammation plays a role in various chronic diseases, but its association with bronchiectasis severity is not well-defined.
- Tumor necrosis factor alpha (TNF-alpha) is a key pro-inflammatory cytokine implicated in chronic inflammatory processes.
Purpose:
- To investigate the relationship between plasma concentrations of TNF-alpha, a marker of systemic inflammation, and established measures of bronchiectasis severity.
- To analyze this association in clinically stable patients with non-cystic fibrosis bronchiectasis.
Summary:
- Plasma TNF-alpha levels were significantly higher in bronchiectasis patients compared to healthy controls.
- Elevated TNF-alpha correlated with other systemic inflammation markers (ESR, CRP, neutrophil percentage).
- Patients with high TNF-alpha exhibited more severe bronchiectasis, increased risk of respiratory failure, and higher rates of Pseudomonas aeruginosa colonization.
Impact:
- This study highlights TNF-alpha as a potential biomarker for assessing bronchiectasis severity.
- Findings suggest that systemic inflammation contributes to disease progression and complications in bronchiectasis.
- Understanding this link may inform future therapeutic strategies targeting inflammation in bronchiectasis management.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...